Antengene Advances Key R&D Programs in Biotech Pipeline
SHANGHAI and HONG KONG, August 18, 2026 Antengene Corporation Limited, a commercial-stage global biotechnology company focused on innovative therapies...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
SHANGHAI and HONG KONG, August 18, 2026 Antengene Corporation Limited, a commercial-stage global biotechnology company focused on innovative therapies...
CAMPBELL, Calif., August 18, 2026 Enlil, Inc. has introduced a four-layer governed AI architecture designed to help medical device...
MORRISVILLE, N.C., August 18, 2026 Syneos Health announced continued expansion of its AI-powered clinical development ecosystem, bringing together artificial...
Tokyo, Japan, August 5, 2026 Kirin Holdings Co., Ltd. and GenerativeX Inc. have launched a new research model that...
Sunnyvale, Calif., August 10, 2026 Ceribell, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted 510(k)...
Waltham, Mass., August 10, 2026 Spyre Therapeutics, Inc. announced the launch of its SPY772 combination program and initiation of...
Bagsværd, Denmark, August 10, 2026 Novo Nordisk and Amazon Web Services (AWS) announced a strategic partnership aimed at accelerating...
LONDON, June 25, 2026 Evaluate, a Norstella company and a leading provider of pharmaceutical market intelligence, has been recognized...
NORTH CHICAGO, Illinois, and SAN FRANCISCO, California, June 22, 2026 AbbVie has announced a definitive agreement to acquire Apogee...
SYDNEY, Australia and AUCKLAND, New Zealand, June 21, 2026 Murj®, a leading provider of cardiac device management software, has...
